Literature DB >> 17869990

Dexmedetomidine as sole sedative for awake intubation in management of the critical airway.

Basem Abdelmalak1, Laila Makary, Jeremy Hoban, D John Doyle.   

Abstract

We report a series of successful awake fiberoptic intubations in patients with critical (unstable, difficult) airways using the alpha(2)-agonist, dexmedetomidine. Dexmedetomidine has several desirable pharmacologic properties, including sedation, anxiolysis, hypnosis, analgesia, amnesia, antisialagogue effects, and a unique respiratory-sparing effect. Dexmedetomidine appears to be a useful agent for sedation during awake fiberoptic intubation in difficult airway patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17869990     DOI: 10.1016/j.jclinane.2006.09.006

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  28 in total

1.  Dexmedetomidine for anesthetic management of anterior mediastinal mass.

Authors:  Basem Abdelmalak; Nicholas Marcanthony; Joseph Abdelmalak; Michael S Machuzak; Thomas R Gildea; D John Doyle
Journal:  J Anesth       Date:  2010-05-08       Impact factor: 2.078

2.  Angioedema after tPA: what neurointensivists should know.

Authors:  Jennifer E Fugate; Ejaaz A Kalimullah; Eelco F M Wijdicks
Journal:  Neurocrit Care       Date:  2012-06       Impact factor: 3.210

Review 3.  Practical anesthetic considerations in patients undergoing tracheobronchial surgeries: a clinical review of current literature.

Authors:  Sanchit Ahuja; Barak Cohen; Jochen Hinkelbein; Pierre Diemunsch; Kurt Ruetzler
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

4.  One case with dexmedetomidine-induced stuporous state in epileptic patient undergoing abdominal surgery.

Authors:  Dong-Ji Han; Zhi-Gang He; Zhi-Qiang Zhou; Li Feng; Cheng Liu; Yan Xiang; Hong-Bing Xiang
Journal:  Am J Neurodegener Dis       Date:  2017-07-25

Review 5.  Dexmedetomidine for the management of awake fibreoptic intubation.

Authors:  Xing-Ying He; Jian-Ping Cao; Qian He; Xue-Yin Shi
Journal:  Cochrane Database Syst Rev       Date:  2014-01-19

6.  Dexmedetomidine as sole agent for awake fiberoptic intubation in a patient with local anesthetic allergy.

Authors:  Maxime Madhere; David Vangura; Alik Saidov
Journal:  J Anesth       Date:  2011-05-07       Impact factor: 2.078

7.  Dexmedetomidine versus remifentanil sedation during awake fiberoptic nasotracheal intubation: a double-blinded randomized controlled trial.

Authors:  Rong Hu; J X Liu; Hong Jiang
Journal:  J Anesth       Date:  2012-10-17       Impact factor: 2.078

8.  Sole use of dexmedetomidine for sedation and analgesia in patients undergoing endovenous thermal ablation for incompetent saphenous veins.

Authors:  Jin Ho Hwang; Il Soo Chang; Sang Woo Park; Won-Kyoung Kwon; Jae Joon Hwang
Journal:  Ann Transl Med       Date:  2019-11

9.  Evaluation of retrograde intubation with different doses of dexmedetomidine infusion: A randomised controlled trial.

Authors:  Tanmay Tiwari; Ashish Walian; Vipin Kumar Singh; Vinita Singh; Sangeeta Chakraborty; Amber Rawat
Journal:  J Oral Biol Craniofac Res       Date:  2020-06-18

10.  Dexmedetomidine versus Remifentanil for Sedation during Awake Fiberoptic Intubation.

Authors:  Davide Cattano; Nicholas C Lam; Lara Ferrario; Carmen Seitan; Kash Vahdat; Darrell W Wilcox; Carin A Hagberg
Journal:  Anesthesiol Res Pract       Date:  2012-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.